2-NBDG: Fluorescent Glucose Analog for Quantitative Glucose Uptake Assay

Executive Summary: 2-NBDG (2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose) is a water- and ethanol-soluble fluorescent glucose analog that enters cells via glucose transporters and is retained after phosphorylation by hexokinase, enabling real-time analysis of glucose uptake [APExBIO B6035]. It supports high-sensitivity assays in flow cytometry, fluorescence microscopy, and microplate formats, and is validated across cell types and disease models including HepG2, MCF-7, L6, and primary astrocytes [Hong et al., 2025]. Uptake kinetics are rapid (plateauing within 20–30 min), and the compound is used in diabetes, tumor, and epilepsy research [MoleculeProbes.net]. The B6035 kit enables standardized, reproducible quantification of glucose transporter function and metabolic flux in vitro and in vivo [cy5-nhs-ester.com].

Biological Rationale

Glucose is the primary energy source for most mammalian cells. Accurate quantification of cellular glucose uptake is essential for understanding metabolic activity and disease pathogenesis, including diabetes, cancer, and neurological disorders [Hong et al., 2025]. Traditional radiolabeled tracers have limitations in safety and throughput. Fluorescent glucose analogs like 2-NBDG provide a non-radioactive, real-time alternative for measuring glucose transport and metabolism [MoleculeProbes.net]. The ability to monitor glucose uptake in live cells and tissues enables dynamic studies of metabolic regulation, transporter activity, and the effects of pharmacological agents or genetic modifications.

Mechanism of Action of 2-NBDG

2-NBDG is a fluorescently labeled 2-deoxyglucose analog. It is transported into cells through glucose transporter proteins (mainly GLUTs). Upon entry, 2-NBDG is phosphorylated by hexokinase, producing 2-NBDG-6-phosphate, which is membrane-impermeant and thus retained inside the cell [APExBIO Product Page]. The NBD (7-nitrobenz-2-oxa-1,3-diazol-4-yl) fluorophore enables direct quantification using standard flow cytometry (excitation ~465 nm, emission ~540 nm), fluorescence microscopy, or microplate readers [cy3-nhs-ester-for-2d-electrophoresis.com]. Unlike radiotracers, 2-NBDG allows for repeated, live-cell measurements and multiplexing with other fluorescent probes.

Evidence & Benchmarks

• 2-NBDG uptake in MCF-7 cells shows rapid signal accumulation within 1–5 min and plateaus by 20–30 min at 10 μM concentration (37°C, PBS) (APExBIO B6035).
• Validated for use in HepG2 hepatocarcinoma, L6 skeletal muscle, MCF-7 breast cancer, and primary astrocyte cultures, with reproducible results across cell types (MoleculeProbes.net).
• Applicable in disease models: 2-NBDG is used to localize epileptic foci in Sprague–Dawley rats and assess glucose uptake in diabetes and tumor xenografts (Hong et al., 2025).
• Solubility: ≥17.1 mg/mL in water (with ultrasonication), ≥2.93 mg/mL in ethanol (with warming and ultrasonication) (APExBIO B6035).
• Standard assay: 10 μM 2-NBDG, 10 min incubation at 37°C for most cell lines (cy5-nhs-ester.com).

Applications, Limits & Misconceptions

2-NBDG is widely used in research on glucose metabolism, diabetes, epilepsy, hyperglycemia, and cancer biology. It is compatible with flow cytometry, fluorescence microscopy, and microplate-based assays, allowing high-throughput and single-cell analyses [cy3-nhs-ester-for-2d-electrophoresis.com]. The compound enables studies of glucose transporter regulation, metabolic flux, and drug effects in vitro and in animal models [fluoresceintsa.com].

Common Pitfalls or Misconceptions

• 2-NBDG is not metabolized beyond the first phosphorylation step; it does not report downstream glycolytic activity or mitochondrial metabolism.
• The fluorescence signal reflects initial glucose uptake, not total intracellular glucose levels or metabolic fate.
• Insolubility in DMSO: 2-NBDG must be dissolved in water or ethanol; improper solvent use reduces assay performance (APExBIO).
• Long-term storage of aqueous or ethanol solutions is not recommended due to potential degradation; prepare fresh stocks as needed.
• Background autofluorescence can confound signal; appropriate negative controls are essential in experimental design.

Compared to the overview in this article (which summarizes general use in cell-based glucose uptake), the present guide provides updated, benchmarked performance data and clarifies practical limits of 2-NBDG in advanced metabolic assays.

Workflow Integration & Parameters

2-NBDG (APExBIO SKU B6035) is supplied as a crystalline solid. For optimal dissolution, add water (≥17.1 mg/mL with ultrasonication) or ethanol (≥2.93 mg/mL with gentle warming and ultrasonication) [product page]. Stock solutions should be stored below -20°C for several months, but avoid long-term storage of diluted solutions. Typical assays use 10 μM 2-NBDG, incubated for 10 min at 37°C. Uptake kinetics vary by cell type; in MCF-7 cells, signal plateaus after 20–30 min. After incubation, cells are washed with cold PBS to remove excess probe prior to analysis by flow cytometry or microscopy. For animal models, 2-NBDG can be administered systemically to localize metabolic hotspots, as demonstrated in rat epilepsy models (Hong et al., 2025).

This guide extends the scenario-based protocol optimization discussed in "Solving Glucose Uptake Assay Challenges with 2-NBDG (SKU B6035)" by providing peer-reviewed benchmarks and clarifying solvent and storage requirements.

Conclusion & Outlook

2-NBDG is a robust, validated fluorescent glucose analog for quantitative measurement of cellular glucose uptake. Its utility spans cell lines, primary cells, and animal models, supporting research in metabolic disease, oncology, and neuroscience. As a product of APExBIO, 2-NBDG (SKU B6035) offers standardized, reproducible workflows and is supported by extensive peer-reviewed validation. However, interpretation should be limited to initial glucose transporter activity, and downstream metabolic steps require complementary assays. Future directions include multiplexing with additional metabolic probes and refinement for high-throughput screening platforms. For further technical specifics and ordering information, refer to the official product page.

For additional context, the article "2-NBDG: Fluorescent Glucose Analog for Quantitative Glucose Uptake" offers a broader methodological review, whereas the present dossier details 2-NBDG's specific strengths, validated parameters, and integration in advanced metabolic assays.